Alzchem Group (ACT.DE) Stock Price
Alzchem Group Price
Revenue has compounded at 15.2% per year over the past 25 years to 562.12 M EUR. Earnings per share have grown at 15.3% per year over the last 8 years. Alzchem Group's net margin stands at 11.3%, up from 6.5% several years earlier. Alzchem Group currently offers a dividend yield of about 1.10%. The payout ratio is around 29% of earnings. The dividend has grown at 7.3% per year over the past 7 years. Analysts set a median price target of 178.50 EUR, implying 9.5% above the current price. Of 10 analysts, 9 rate the stock a buy — an overall Buy consensus.
Alzchem Group stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Alzchem Group business model & stock analysis
Frequently asked questions about Alzchem Group
The business model of AlzChem Group AG revolves around specialty chemicals and pharmaceuticals. AlzChem Group AG is a global supplier of various chemical products used in a wide range of industries such as agriculture, nutrition, and fine chemicals. The company focuses on manufacturing, marketing, and developing innovative chemicals that meet the specific needs of its customers. AlzChem Group AG aims to provide high-quality products that contribute to the growth and success of its clients, while also ensuring environmental sustainability and maintaining high safety standards. With its diverse portfolio and commitment to excellence, AlzChem Group AG stands as a leading player in the specialty chemicals industry.
AlzChem Group AG is primarily active in the chemical industry.
The main competitors of AlzChem Group AG in the market include companies such as BASF SE, Evonik Industries AG, and LANXESS AG. These companies operate in similar industries and offer a range of products that may compete with AlzChem Group AG's offerings. However, AlzChem Group AG has established itself as a leading player in specialty chemicals and innovative chemical products, continually striving to maintain a competitive edge through its strong market position, research and development capabilities, and customer-focused approach.
AlzChem Group AG is a leading specialty chemicals company based in Germany. With a rich history dating back over 100 years, AlzChem has grown into a global player in the chemical industry. Initially established as a producer of calcium cyanamide, the company has continuously expanded its portfolio to include a diverse range of products and applications. AlzChem focuses on three main business segments: Specialty Chemicals, Nutrition and Feed, and Performance Materials. By leveraging its expertise and state-of-the-art facilities, AlzChem actively contributes to the development of innovative solutions in various industries, including agriculture, pharmaceuticals, and automotive. With a commitment to sustainability and customer satisfaction, AlzChem Group AG continues to shape the future of chemical manufacturing.
AlzChem Group AG, a leading specialty chemicals company, has achieved several significant milestones. Notably, the company successfully completed its IPO in 2017, enabling it to expand its shareholder base and increase financial resources for future growth. AlzChem Group AG has also made noteworthy advancements in its production capabilities and technology, driving innovation and expanding its product portfolio. In addition, the company has achieved numerous certifications and accreditations, demonstrating its commitment to quality and sustainability. Furthermore, AlzChem Group AG has established strategic partnerships with key industry players, fostering collaborations and enhancing its market presence. Such milestones highlight the company's strong growth trajectory and position it as a reputable player in the specialty chemicals industry.
AlzChem Group AG is primarily present in Germany, where its headquarters are located. Additionally, the company has a strong presence in other European countries such as Austria, France, and the United Kingdom. With its wide range of chemical products, AlzChem Group AG also operates in international markets, including the United States and China.
AlzChem Group AG represents values of innovation, sustainability, and responsibility. With a strong focus on research and development, the company is committed to delivering high-quality products and solutions to its customers. AlzChem Group AG also believes in fostering long-term partnerships and maintaining a customer-centric approach. The company's corporate philosophy emphasizes ethical business practices, environmental stewardship, and the well-being of its employees. By prioritizing these values, AlzChem Group AG aims to create value for its shareholders while contributing to the sustainable progress of society.
Analysts currently set an average price target of 180.48 EUR for the Alzchem Group stock (median: 178.50 EUR), implying +10.7 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Alzchem Group stock: 9 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Alzchem Group to generate revenue of 608.06 M EUR and earnings per share of 6.56 EUR.
The Alzchem Group share (ACT.DE) is listed on 8 stock exchanges, including: London (0ACT.L), SIX (Zürich) (SFP1.SW), XETRA (ACT.DE), Frankfurt (ACT.F), München (ACT.MU), Düsseldorf (ACT.DU), Berlin (ACT.BE).
The AlzChem Group AG is a company located in Trostberg, Bavaria, specializing in the development, production, and marketing of specialty chemicals. The company was founded in 1908 and has been listed on the stock exchange since 2007. The AlzChem Group AG is divided into three divisions: Specialty Chemicals, Basic Chemicals, and Nutrition. Each division has its own products and target markets. The Specialty Chemicals division specializes in the production and marketing of specialty chemicals for applications in agriculture, energy, pharmaceuticals, plastics, and electronics. Examples of products in this division include dicyandiamide, guanidine hydrochloride, and hydrazine hydrate. These chemicals are used in a variety of industrial processes to improve their technical and functional properties. The Basic Chemicals division produces and distributes basic chemicals such as phenol, acetone, melamine, and cyanamide. These chemicals are used by other companies as raw materials in the production of various products. For example, phenol is used in the production of plastics, resins, and paints. Cyanamide is used as a crop protection agent. The Nutrition division specializes in the production of dietary supplements and pharmaceutical active ingredients. The company offers products such as creatine and arginine, which are appreciated by athletes and fitness enthusiasts as dietary supplements. The AlzChem Group AG has an established business model based on the production and marketing of specialty chemicals. The company is able to bring new and innovative products to the market through targeted research and development, as well as investments in modern production technologies. The production capacities are sufficient to produce larger quantities of products. Additionally, high product quality and reliable delivery to customers are guaranteed. The AlzChem Group AG targets customers from various industries, including agriculture, energy, pharmaceuticals, plastics, and electronics. As a publicly traded company, the AlzChem Group AG aims to achieve profitable and stable growth. A smart financial strategy and efficient risk management are therefore important elements of the business model. Networks and partnerships with other companies and research institutions are another important element of the business model and are intended to expand the market potential and explore new business areas. Overall, the AlzChem Group AG is a successful company known for its wide range of products and target markets. The strengths of the company lie in targeted research and development, as well as the high quality of its products and services.
The expected revenue of Alzchem Group is 608.06 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Alzchem Group is 66.29 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Alzchem Group is currently 24.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Alzchem Group stock.
The price-to-sales ratio (P/S) of Alzchem Group is currently 2.71. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Alzchem Group stock.
The Eulerpool Quality Score for Alzchem Group is 6/10.
The ISIN of Alzchem Group is DE000A2YNT30. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Alzchem Group is A2YNT3. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Alzchem Group is ACT.DE. The ticker symbol is used to trade Alzchem Group shares on the stock exchange.
Alzchem Group stock
Alzchem Group Peer Group
Alzchem Group Ticker
Alzchem Group FIGI
All fundamentals and in-depth analysis of Alzchem Group
Our stock analysis for Alzchem Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alzchem Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.